EQL Pharma AB (publ) (STO:EQL)

EQL Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	672	1,606	2,064	1,229	1,087	974
Market Cap Growth	-63.31%	-22.15%	67.85%	13.10%	11.64%	-2.05%
Enterprise Value	1,070	1,971	2,205	1,317	1,075	1,010
Last Close Price	21.35	54.40	71.00	42.30	37.40	33.50

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	-	128.12	47.85	54.15	35.15	30.86
Forward PE	17.64	29.17	31.21	16.99	-	-
PS Ratio	1.63	3.71	5.53	4.65	4.18	2.38
PB Ratio	2.81	6.02	9.34	6.92	7.02	7.88
P/TBV Ratio	-	-	-	42.91	20.82	38.62
P/FCF Ratio	33.13	70.10	-	-	40.02	23.63
P/OCF Ratio	33.04	56.64	-	-	39.36	23.28

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	2.55	4.56	5.90	4.99	4.14	2.47
EV/EBITDA Ratio	30.82	29.89	29.38	33.94	22.70	24.92
EV/EBIT Ratio	80.39	41.25	33.03	40.38	26.01	26.01
EV/FCF Ratio	51.92	86.00	-	-	39.59	24.52

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	1.84	1.72	2.06	0.68	0.43	0.62
Debt / EBITDA Ratio	12.86	6.82	5.93	2.98	1.37	1.83
Debt / FCF Ratio	21.67	20.04	-	-	2.45	1.85
Net Debt / Equity Ratio	1.59	1.40	1.69	0.56	0.14	0.28
Net Debt / EBITDA Ratio	11.62	5.65	4.97	2.57	0.47	0.86
Net Debt / FCF Ratio	18.79	16.26	-12.13	-8.06	0.82	0.85
Asset Turnover	0.54	0.52	0.63	0.80	0.99	1.86
Inventory Turnover	1.59	1.42	1.53	1.74	2.69	7.47
Quick Ratio	0.83	0.95	0.97	0.53	0.83	0.77
Current Ratio	1.83	1.92	1.81	1.22	1.43	1.25
Return on Equity (ROE)	-5.84%	5.14%	21.63%	13.66%	22.21%	29.37%
Return on Assets (ROA)	1.06%	3.60%	7.06%	6.18%	9.87%	11.00%
Return on Invested Capital (ROIC)	2.13%	5.33%	12.15%	11.40%	19.56%	21.96%
Return on Capital Employed (ROCE)	2.20%	7.50%	11.40%	15.40%	24.50%	27.90%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	-2.08%	0.78%	2.09%	1.85%	2.84%	3.24%
FCF Yield	3.02%	1.43%	-1.49%	-1.01%	2.50%	4.23%
Buyback Yield / Dilution	1.52%	-0.92%	-0.34%	-0.91%	-1.59%	-

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error